Next Article in Journal
Effect of SiO2 and TiO2 Nanoparticles on the Performance of UV Visible Fluorescent Coatings
Previous Article in Journal
Hydrophilic Surface Treatment of Carbon Powder Using CO2 Plasma Activated Gas
Previous Article in Special Issue
Development of Adhesive, Bioactive and Antibacterial Titania Sol-Gel Coating on Titanium Substrate by Dip-Coating Technique
 
 
Article
Peer-Review Record

A Percutaneous Catheter Solution as a Spacer for Regurgitant Heart Valve Disease

Coatings 2021, 11(8), 926; https://doi.org/10.3390/coatings11080926
by Min-Ku Chon 1, Dong-Hoon Shin 2, Su-Jin Jung 3, Hyeon-Jun Park 3 and June-Hong Kim 1,*
Reviewer 1:
Reviewer 2: Anonymous
Coatings 2021, 11(8), 926; https://doi.org/10.3390/coatings11080926
Submission received: 2 July 2021 / Revised: 27 July 2021 / Accepted: 30 July 2021 / Published: 2 August 2021
(This article belongs to the Special Issue Glass/Ceramic Coatings for Biomaterials and Biomedical Applications)

Round 1

Reviewer 1 Report

The article under review is describing a novel spacer device design for regurgitant valvulopathies that does not require separate fillers to function. While the new design is interesting, the following aspects of the manuscript need to be addressed:

 

  • In the introduction, the authors write: “To overcome these limitations, many studies have been conducted.” Please provide references for this statement.

 

  • Edits that improve the grammar of the article would be highly beneficial.

 

  • The authors write that animal testing was performed for 8 weeks. Have any attempts been made to quantify the durability of the spacer device after longer periods of time? How about other complications, such as the risk of infection?

 

  • In the methods section, the authors write, “A trained veterinarian carried out all procedures.” However, a sufficient description is not given in regards to what the procedures were.

 

  • Clarify in the manuscript what the economic benefit would be from using the new spacer compared with already available solutions.

 

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

This study aimed to evaluate the biocompatibility, during  6-8 weeks, of a ePTFE (expanded-Poly tetra-fluoroethylene) device inserted into the free space of the swine heart.

Introduction can be completed by presenting more information about spacer devices.

The authors say that “To overcome these limitations, many studies have been conducted” but they have only 3 references in the whole manuscript. Comparison with results with other studies should be done in the Discussion section.

The authors mentioned that “We technically have verified that this spacer device was properly implanted at the target position by echocardiography”, so results of the echocardiographic evaluation should be also presented.

The material and methods section can be improved by offering more information about the self-expandable mesh implantation procedure.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

The authors did some suggested improvements.

I can understand that further research is necessary for a better comparison, but in the first version of the manuscript, the authors mentioned "To overcome these limitations, many studies have been conducted." and they chose to delete this part instead of providing the required references.
To improve the manuscript the authors should provide more references.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 3

Reviewer 2 Report

The authors did the suggested improvements.

Back to TopTop